日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer

HDAC2 在卵巢癌染色质重塑和化疗反应中的作用

Rui Huang, Simon P Langdon, Matthew Tse, Peter Mullen, In Hwa Um, Dana Faratian, David J Harrison

Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers

对结直肠癌细胞系进行多尺度基因组学、转录组学和蛋白质组学分析,以鉴定新的生物标志物

Romina Briffa ,Inhwa Um ,Dana Faratian ,Ying Zhou ,Arran K Turnbull ,Simon P Langdon ,David J Harrison

Increased STAT1 signaling in endocrine-resistant breast cancer

内分泌耐药性乳腺癌中 STAT1 信号传导增强

Huang, Rui; Faratian, Dana; Sims, Andrew H; Wilson, Danielle; Thomas, Jeremy S; Harrison, David J; Langdon, Simon P

Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

卵巢上皮癌中类固醇受体共激活因子3的表达是预后不良因素,也是铂类耐药性的标志物。

Palmieri, C; Gojis, O; Rudraraju, B; Stamp-Vincent, C; Wilson, D; Langdon, S; Gourley, C; Faratian, D

Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-κB survival signatures following GNRH receptor activation.

转录组和蛋白质组分析揭示了 GNRH 受体激活后的信号传导、生长停滞、细胞凋亡和 NF-κB 存活特征

Meyer Colette, Sims Andrew H, Morgan Kevin, Harrison Beth, Muir Morwenna, Bai Jianing, Faratian Dana, Millar Robert P, Langdon Simon P

Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer

预测复发性卵巢癌对抗雌激素氟维司群的反应

Peter A Argenta, Inhwa Um, Charlene Kay, David Harrison, Dana Faratian, Thanasak Sueblinvong, Melissa A Geller, Simon P Langdon

The use of reverse phase protein arrays (RPPA) to explore protein expression variation within individual renal cell cancers.

利用反相蛋白芯片(RPPA)探索单个肾细胞癌内的蛋白质表达变异

O'Mahony Fiach C, Nanda Jyoti, Laird Alexander, Mullen Peter, Caldwell Helen, Overton Ian M, Eory Lel, O'Donnell Marie, Faratian Dana, Powles Thomas, Harrison David J, Stewart Grant D

Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer

定义卵巢癌对曲妥珠单抗、帕妥珠单抗和联合疗法的分子反应

A H Sims, A J M Zweemer, Y Nagumo, D Faratian, M Muir, M Dodds, I Um, C Kay, M Hasmann, D J Harrison, S P Langdon

Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 network

基于模型的全局敏感性分析在 ErbB2/3 网络中识别抗癌药物靶点和耐药性生物标志物中的应用

Galina Lebedeva, Anatoly Sorokin, Dana Faratian, Peter Mullen, Alexey Goltsov, Simon P Langdon, David J Harrison, Igor Goryanin

Diversity of matriptase expression level and function in breast cancer

乳腺癌中膜型丝氨酸蛋白酶表达水平和功能的多样性

Arkadiusz Welman ,Duncan Sproul, Peter Mullen, Morwenna Muir, Andrew R Kinnaird, David J Harrison, Dana Faratian, Valerie G Brunton, Margaret C Frame